spacer
home > ict > spring 2019 > the mosaic of patient engagement
PUBLICATIONS
International Clinical Trials

The Mosaic of Patient Engagement

Patient engagement is a ubiquitous concept in the orphan disease space, yet researchers are still vetting methods to implement more broadly based, efficient, and innovative interactions with patients and caregivers across the R&D spectrum. A wealth of potential engagement mechanisms have been suggested throughout the lifecycle of a potential therapeutic, highlighting both opportunities and challenges that can transform the R&D process.

What motivates someone to participate in a clinical trial? Enabling trial participation may require a fundamental shift in the way the pharmaceutical industry traditionally views the clinical trial process, changing the language commonly used to describe concepts such as patient recruitment and retention by adjusting the frame of reference to emphasise patient engagement. It is the patient’s journey, not the destination, that must take centre stage when a more strategic, rather than transactional, mandate is needed.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Barbara Zupancic is Senior Director of Patient Recruitment and Retention at Worldwide Clinical Trials. With nearly 20 years of experience in clinical research, she is responsible for the patient engagement aspects of clinical trials, which includes making trials more accessible to patients, less burdensome for sites, and smoother for sponsors.

Dr Michael Murphy is Chief Medical and Scientific Officer at Worldwide Clinical Trials. With 30 years of pharma experience, he is responsible for enabling strategic clinical research consultation and protocol development services for Phases 1-4 across therapeutic areas within Worldwide Clinical Trials.
spacer
Barbara Zupancic
spacer
spacer
spacer
Dr Michael Murphy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement